Recent studies have shown that host-reactive interleukin-2 (IL-2)-secreting donor T lymphocytes (TI) are critically involved in the development of acute graft-versus-host disease (GVHD) after allogeneic HLA-identical sibling bone marrow transplantation (BMT). To further characterize the responding TI, we determined the frequency of pretransplant IL-2-secreting TI-precursors (TI-p) between eight HLA-A, -B, -C, -DR, and -DQ-identical sibling donor-host pairs in both the graft-versus-host (GVH) and the host-versus-graft (HVG) direction. High frequencies of pretransplant host-reactive donor TI-p (1 /I 8,000 to 1 /49,000) were detectable in five patients with grade II acute GVHD. Donor-reactive host TI-p (1/3,700 to 1/31,000) were observed in previously in vivo primed (n = 5) and unprimed (n = 1) patients. In two pairs tested after previous in vivo priming, pretransplant donor-reactive host TI-p were ESPITE IMPROVEMENTS in posttransplant immu-D nosuppressive therapy, acute graft-versus-host disease (GVHD), mediated by host-reactive donor T cells present in the bone marrow (BM) inoculum, still remains a serious and often life-threatening complication after non-T-cell-depleted allogeneic BM transplantation (BMT).'>* Tcell depletion of the donor marrow, although very effective in preventing acute GVHD, has been associated with a significant increase in the incidence of graft reje~tion,~ mediated by donor-reactive host T cells surviving the pretransplant conditioning radiotherapy and chemotherapy After genotypically HLA-identical sibling BMT, hostreactive donor and donor-reactive host T cells are, by definition, directed against minor histocompatibility (mH) antigens presented in the context of molecules encoded by the major histocompatibility complex (MHC).6,7 However, it cannot be excluded that disparate oligonucleotide-defined HLA-DPB 1 alleles, infrequently expressed between sibling pairs presumed to be HLA-identical, also serve as target molecules for responding T cells.'
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highly enriched within the CD45RO+ memory T-cell subset. Previously unprimed host-reactive donor TI-p occurred in almost equal frequencies within CD45RO+ and CD45RO-T cells. Both CD4+ and CD8+ T-cell subsets contributed in comparable frequencies to host-and donorreactive TI-p. Recognition of minor histocompatibility (mH) antigens by CD8+ TI-p appeared to be class I major histocompatibility complex (MHC)-restricted, whereas CD4 + TI-p operated in a class II (HLA-DR) MHC-restricted fashion. Even between oligonucleotide-defined HLA-DPBI -disparate sibling donor-host pairs (n = 3). either responding T-cell subset was found to recognize cellularly defined mH antigens. These data indicate that various T-cell subsets contribute to host-and donor-reactive IL-2-secreting TI in allogeneic sibling BMT. 0 1993 by The American Society of Hematology.
lymphocytes (TI) to the induction of acute GVHD has been suggested. More recently, we have shown that a high frequency of pretransplant host-reactive interleukin-2 (IL-2)-secreting donor TI-precursors (TI-p) precisely predicts clinically significant acute GVHD in HLA-identical sibling BMT.I6 The relevance ofthis finding has been confirmed in the posttransplant setting." However, the responding T1-p have not yet been characterized.
To this end, we determined the frequency of pretransplant IL-2-secreting TI-p between genotypically HLA-A, -B, -C, -DR, and -DQ-identical sibling donor-host pairs in both the graft-versus-host (GVH) and the host-versus-graft (HVG) direction. Responding TI-p were further analyzed with respect to the cell surface phenotype, the influence of previous in vivo priming, the MHC class restriction of mH antigen recognition, and the impact of disparate HLA-DPB 1 alleles.
MATERIALS AND METHODS
Patients. Eight sibling donor-host pairs were used in the study. The relevant clinical details of the study group are listed in Table 1 . Patients were selected in part for posttransplant development of acute GVHD and previous in vivo priming. All patients received non-T-cell-depleted marrow grafts in the BMT-Unit of the Ulm University Hospital (Ulm, Germany). Cyclosporine (CsA) and methotrexate (Mtx) were administered as posttransplant GVHD prophylaxis.' The diagnosis of acute and chronic GVHD was established by clinical and histopathologic criteria." Chronic GVHD was classified according to Sullivan et aI.l9 Five patients developed grade I1 acute GVHD. Three patients never showed any clinical signs of acute GVHD. One patient developed secondary chronic GVHD and one patient developed primary chronic GVHD. Seven patients have been pretransfused with multiple blood products. Graft rejection was observed in none of the patients.
The culture medium used was RPMI-1640 (Biochrom, Berlin, Germany) supplemented with 10% (vol/ vol) heat-inactivated pooled human AB serum, 25 mmol/L Cell culture medium. HEPES, 2 mmol/L L-glutamine, 100 pg/mL streptomycin, and 100 U/mL penicillin.
Heparinized peripheral blood (PB) was collected before the transplant from the host and donor and from HLA-typed unrelated healthy volunteers after informed consent. PB mononuclear cells (PBMC) were obtained by centrifugation of the diluted blood over Ficoll-Hypaque (density [6] = 1.077 g/mL; Biochrom). Cells were washed twice in phosphate-buffered saline (PBS; GIBCO Ltd, Paisley, UK) and cryopreserved in the vapor phase of liquid nitrogen. Before use, cells were immediately thawed, washed twice in PBS, and resuspended in complete medium. PBMC served as responder and stimulator cells.
In vitro Epstein-Barr virus-transformed B-lymphoblastoid cell lines (EBV-LCL).
For the establishment ofdonor and host as well as unrelated EBV-LCL, E-rosette-purified T and non-T cells were prepared from PBMC by incubation with neuraminidase-treated sheep red blood cells (SRBC), as previously described.20,21 Non-T cells (5 X 106/mL) were infected for 4 hours at 37°C with mycoplasma-free supernatant (SN) ofthe EBV-producing B95.6 cell line. After washing, EBV-infected cells were maintained in RPMI-1640 supplemented with 10% (vol/vol) heat-inactivated fetal calf cerum (FCS; Biochrom). Continuously growing EBV-LCL were found to be free of mycoplasma contamination on repeated testing. EBV-LCL served as restimulator cells.
Stimulator and restimulator cells were irradiated with 20 C y and 40 Cy, respectively, from a I3'Cs source (NuclearData, Frankfurt, Germany).
HLA typing of PBMC as well as HLA retyping of EBV-LCL from pretransplant sibling donorhost pairs and unrelated healthy volunteers were performed by conventional serotyping of HLA-A, -B, -C, -DR, and -DQ alleles and by oligonucleotide typing of HLA-DPB 1 alleles.22 The latter method allowed by computer-based selection of I7 sequence-specific oligo- tem.z3 All sibling donor-host pairs used in the study were negative in the standard mixed lymphocyte culture (MLC) and the lymphocyte cross-match. As summarized in Table 2 , five of eight donorhost pairs were genotypically matched for HLA-A, -B, -C, -DR, -DQ, and -DPBI alleles. Disparate DPBl specificities were detectable within donor-host pairs no. I (GVH and HVG direction), 4 (HVG direction only), and 6 (HVG direction only). The hosts in pairs no. 4 and 6 were homozygous for DPBl*0101 and DPB1*0201, respectively. Negative MLC and typing results of other family members were consistent with the identity of DRl1 specificities between donor and host in sibling pairs no. 4 and 6.
Monoclonal antibodies (MoAbs). Fluorescein isothiocyanate (F1TC)-conjugated and phycoerythrin (PE)-coupled MoAbs IOT4a
(anti-CD4) and IOT8a (anti-CD8) were purchased from DianovaImmunotech (Hamburg, Germany). FITC-conjugated MoAb UCHL-1 (anti-CD45RO) was obtained from Dako (Hamburg, Germany). L243, w6/32, and B7/2 I are directed against the HLA-DRa chain, class I nonpolymorphic determinants, and HLA-DP, respectively. Tu22 (anti-HLA-DQ) was obtained from Biotest (Frankfurt, Germany). Each MoAb was used in predetermined saturating concentrations.
Separation of T-cell subpopulations. CD4+8-, CD8+4-, CD45RO+, and CD450RO-T-cell subsets were sorted with an EPICS I1 cell sorter (Coulter Electronics, Hialeah, FL). For singleand dual-color analyses and sorts, E-rosette-purified T cells were labeled with MoAbs IOT4a-FITC, IOT8a-PE, and UCHL-1-FITC. Before analysis and sorting, the cells were washed twice in PBS containing 5% (vol/vol) human AB serum. Labeling procedures were performed at 4°C for 20 to 30 minutes. The punty of the cell populations, sorted according to forward-angle light scatter and fluorescence intensity, exceeded 95% as determined by reanalysis. Separated T-cell subpopulations served as responder cells.
The methodologic details of LD analysis of human IL-2-secreting TI-p have been recently reported.'6,20.21 In brief, replicate microcultures (n = 16) were set up in 96-well V-shaped microtiter plates (Nunc, Wiesbaden, Germany) with graded numbers of pretransplant donor or host re-
Limiting dilution (LO) cultures.
For personal use only. on August 16, 2017 . by guest www.bloodjournal.org From 300 THEOBALD AND BUNJES Clonal specijicity analysis. Clonal specificity analysis was performed with replicate microcultures (n = 160 to 320), each containing fixed responder cell numbers giving a probability of clonality in positive IL-2-producing colonies of greater than 90%, as calculated from the respective predetermined frequency values.
For inhibition of IL-2 production, 1 X lo4 to 4 X IO4 CD4+8-and CD8+4-donor or host T cells were cocultured with 5 X IO' irradiated host or donor EBV-LCL stimulator cells in triplicate wells of V-bottom microtiter plates in a final volume of 150 pL. Stimulator LCL were preincubated for 2 hours at 37°C with predetermined saturating concentrations of MoAbs w6/32, L243, Tu22, and B7/2 I or with medium only. After 48 hours, SN were removed and transferred to flat-bottom microtiter plates for IL-2 analysis.
Assay for ZL-2 activity. IL-2 activity was determined using a colorimetric bioassay as recently described. mg/mL) was added. Three hours later, 100 pL of a solution of 10% sodium dodecyl sulfate (SDS) and 0.01 N HCI was added to each microwell. After overnight incubation, the optical density (OD) of individual microwells was read at a wavelength set to 570 nm using a Nunc enzyme-linked immunosorbent assay (ELISA) reader (Model NJ-2000). The maximum MTT cleavage was assessed in two wells containing 20 U rIL-Z/mL. All microcultures with an OD that exceeded the mean OD plus three times the standard deviation (SD) of control cultures containing stimulator cells only were considered as positive.
Statistical analysis. Calculation of frequencies from LD analysis was based on Poisson distribution. The values for the frequency, 95% confidence limits for the frequency, and the probability for single-hit kinetics were calculated by likelihood maximization and x2 minimization as described by Ta~we11.~~ Frequencies of TI-p are only shown ifthe Pvalue (probability for single-hit kinetics) and the x2 value were >.05 and less than 10, respectively.
RESULTS

Frequency of host-reactive TI-p.
High frequencies of pretransplant host-reactive d o n o r TI-p ( I / 18,000 to 1/49,000) were detectable in five patients with subsequent development of grade I1 acute G V H D (Table 3) . Only low frequencies of responding TI-p ( 1 / 1 10,000 to frequencies not detectable) were observed after autologous stimulation. In three patients without acute G V H D , TI-p frequencies were either beyond t h e threshold of detectability (< 1/ 400,000) or corresponded to an autologous background response (1/2 17,000 and 1/222,000). Frequencies of allo-MHC-reactive donor TI-p (]/SO0 to 1/13,000) were higher i n magnitude as compared with host-reactive TI-p throughout.
Pretransplant donorreactive host T1-p (frequency, 1/3,700 to 1/31,000) were detectable in pretransfused (n = 5) and untransfused (n = I ) patients (Table 4) . A rather low autologous background reactivity was observed (frequency 1/132,000 to levels not de-
Frequency of donor-reactive TI-p.
For personal use only. on August 16, 2017 . by guest www.bloodjournal.org From (Tables 3 and  4 ). The same was evident, although to a lower extent, for allo-MHC-reactive host (mean, 1 /800) versus donor TI-p (mean, 1/2,000). Because five of six patients with a pretransplant donor-specific TI-p response had been previously in vivo primed by multiple blood transfusions (Tables I and  4 ), one would expect that donor alloantigens preferentially recruit CD45RO+ memory host T cells. Among two sibling pairs tested, pretransplant in vivo primed donor-reactive host TI-p (HVG direction) were, in fact, highly enriched within the CD45RO+ memory T-cell subset ( Table 5 ). In contrast, pretransplant unprimed host-reactive donor T1-p (GVH direction) occurred in almost equal frequencies within CD45RO' and CD45RO-T cells. Individual frequencies of either responding T-cell subset were rather comparable in magnitude to those shown within unseparated PBMC (Tables 3 and 4) .
To identify the cellular origin of IL-2 production, the frequencies of responding TI-p were analyzed within CD4'8-and CD8'4-T-cell subsets. As shown in Table 6 , both CD4+ and CD8+ T cells contributed to host-and donor-reactive T1-p in four of five cases. In three of four cases, CD8+ T cells were somewhat depleted of responding T1-p as compared with the CD4+ phenotype. The relative frequency distribution of individual T-cell subsets corresponded well to respective frequency values estimated within unseparated PBMC (Tables 3 and  4) , CD45ROf, and CD45RO-T-cell subpopulations ( Table  5) . A clonally host-and donor-specific response was detectable for both CD4' and CD8+ donor and host T1-p (data not shown).
HLA-DPB 1 allele disparities were detectable within three sibling donorhost pairs in either the GVH and HVG directions (no 1) or in the HVG direction only (nos. 4 and 6) ( Table 2 ). The ability to detect responding TI-p in these pairs seemed to be independent of the presence of DPB 1 mismatches (Tables 3  through 6 ). To address this issue in more detail, we analyzed whether DPB l *O 10 l served as target molecule for donor-reactive CD4+ and CD8+ host T1-p in donor-host pair Frequency of CD4+ and CD8' Tl-p.
Influence of disparate HLA-DPBI alleles. Frequencies of IL-2-secreting T cells were calculated according to Poisson distribution. Abbreviations: 95% CL, 95% confidence limit for each frequency value; P, probability of single-hit kinetics no. 1. As shown in Fig I , clonal specificity analysis clearly indicates that third-party antigen WW, sharing only DPB 1 *O I O 1 with primary stimulating donor cells, was not corecognized by CD4+ and CD8+ host TI-p. To confirm this finding, MoAb B7/21 (anti-DP) was tested in predetermined saturating concentrations to inhibit the IL-2 production of donor-reactive host TI between sibling donor-host pairs no. 1 (DPB 1 *O I O 1 mismatch in HVG direction) and no. 4 (DPB I *040 1 mismatch in HVG direction). As shown in Table 7 MoAb B7/2 1 did not interfere with the ability of donor-reactive host T1 to secrete IL-2. Thus, responding T1-p were most likely directed to mH antigens, even between these DPB 1-mismatched pairs.
MHC class restriction of mH-specific CD4+ and CD8+ TI-p. The relevant class I and class I1 MHC restriction molecules for anticipated mH antigen recognition by either Tcell subset were cellularly defined by the same series of experiments ( Table 7) . IL-2 production of mH-specific CD4+ and CD8' T1 was inhibited by MoAbs L243 (anti-DR) and w6/32 (anti-class I), respectively. In contrast, MoAb Tu22 (anti-DQ) caused no significant inhibition of IL-2 produc- Frequencies of IL-2-secreting T cells were calculated according to Poisson distribution.
Abbreviations: 95% CL, 95% confidence limit for each frequency value; P, probability of single-hit kinetics; ND, not detectable (frequency < 1 /200,000); NA, not applicable.
tion by either T-cell subset. Accordingly, mH-specific CD8' TI appeared to be class I MHC-restricted, whereas mH-specific CD4' T1 seemed to operate in a class I1 (DR) MHC-restricted fashion. Using frequency and clonal specificity analyses, the MHC-class restriction patterns of mH-specific CD8+ and CD4+ T1-p between sibling pair no. 4 were confirmed by their differential recognition of a limited number of, in part, HLA-matched third-party restimulator cells (data not shown).
DISCUSSION mH-specific IL-2-secreting T1-p were quantitatively assessed pretransplant and further characterized by LD technology. High frequencies of host-reactive donor TI-p seemed to precede the development of acute GVHD. Donor-reactive host T1-p were found in previously in vivo primed and unprimed patients. Other factors, such as sex mismatch and previous donor pregnancy, did not seem to correlate with the T1 response.
Previous in vivo priming has been considered a prerequisite for the induction of mH-specific T cells.17 One of the striking findings of the present and previous studied6 was the pretransplant detection of mH-specific IL-2-secreting TI-p in the absence of any in vivo priming. In the murine system, primary in vitro generation of previously unprimed mH-specific T cells requires the use of exogenous IL-2 and transformed stimulator ~e l l s . '~,~~ As an analogy, we also used exogenous IL-2 and transformed B-lymphoblastoid restimulator cells.
After in vivo priming by blood transfusions, the frequencies of mH-and allo-MHC-reactive host TI-p were higher as compared with those of previously unprimed donor TI-p. It is not a matter of debate that in vivo polysensitization to mH antigens facilitates the in vitro generation of mH-reactive T
The high frequency values of in vivo primed mH-specific TI-p were not altogether unexpected, because similar high frequencies of mH-specific cytotoxic T-lymphocyte (CTL) precursors (CTL-p) have been reported in heavily pretransfused transplant recipients.27 In addition, blood transfusions from unrelated donors have been shown to increase the frequencies of donor-reactive C T L p and IL-2-secreting Ti-p.2s~29 Among two sibling pairs tested, in vivo primed mH-specific host T1-p were highly enriched within the CD45RO+ memory T-cell susbset. Previously unprimed mH-specific donor TI-p occurred in almost equal frequencies within CD45ROf and CD45RO-T cells. In vitro, CD45RO+ T cells respond to recall antigens almost exclusively and are therefore considered to contain the memory T-cell After in vivo priming with allo-MHC antigens, T-cell memory is potentially long lasting and functionally enriched within CD45RO+ T The response of an previously unprimed individual to allo-MHC antigens may be an exception, as both CD45RO+ and CD45RO-T cells contain similar high levels of reactive precursors and respond with the same proliferative kin e t i c~.~~,~~,~~ An interesting and potentially important observation of the present study is that mH antigens, similar to allo-MHC antigens, seem to activate naive and memory T cells to the same extent in previously unprimed individuals. At present, our data do not offer any explanation for this phenomenon. However, because CD45RO+ and CD45RO-T cells synergize in response to allo-MHC antigens,36 and possibly to mH antigens, this may have detrimental consequences for BMT, in which this synergy may further amplify the anti-graft (graft rejection) and anti-host (GVHD) responses.
HLA-DP is not considered in conventional routine HLAtyping, although it is well known that a proportion of DP incompatibility occurs between siblings presumed to be HLA-identi~al.~' T-cell recognition of oligonucleotide-defined DPBl alleles can be potentially shown by virtue of modified MLC conditions and LD analy~is.~' These T-cell responses are blocked by anti-DP MoAb." In contrast, the responding IL-2-secreting T1 between the few DPB 1 -mismatched sibling pairs reported in the present study did not recognize DPBl alleles and were not inhibited by anti-DP MoAb. Thus, disparate HLA-DP antigens seemed not to be involved in T1 responses between the sibling pairs studied here.
A recent report by Cesbron et aI3' has shown that most of the DP combinations sharing the same amino acid sequence in the third and fourth hypervariable regions (HVR) are associated with a low or even absent proliferative T-cell response in vitro. In the three DPBl-disparate sibling pairs used in the present study, we did not find any correlation between amino acid matching or mismatching in the third and fourth HVR and the T1 responses observed. However, due to a few number of DP-mismatched combinations tested, this finding does not necessarily argue against the relevance of matched or mismatched amino acid sequences in the third and fourth HVR for T-cell recognition of DPB 1 alleles. Accordingly, Cesbron et a139 also reported that the presence or absence of T-cell responses in some DP-mismatched combinations occurs independently of the amino acid sequences in the third and fourth HVR of the DPBl allele.
The relative distribution of murine mH-reactive CD4+ and CD8+ T cells varies according to the particular strain combination examined.'-'* Apart from class I MHC-restricted CD8+ CTL,6 class I1 MHC-restricted CD4+ proliferative T cells have been reported so far in humans posttransplant.I5sa Our study shows that both CD4+ and CD8+ T cells contribute to pretransplant mH-reactive human IL-2-secreting TI-p. Recognition of mH antigens by CD8+ T1-p appeared to be class I MHC-restricted, whereas CD4+ T1-p seemed to operate in a class I1 MHC-restricted fashion.
Involvement of human lymphokine-secreting T1 in the 
